Expenditure of biological drugs for rheumatoid arthritis treatment in the Brazilian public health system.
Tacila Pires MegaRondineli Mendes da SilvaPublished in: Revista de saude publica (2023)
The results obtained allow us to draw a more recent profile of expenditure on RA treatment and indicate trends in the use of biological drugs for this condition, generating data that can support management decisions in public health policies.